Holding ARKG?
Track your performance easily

ARKG Price & Analysis

ARKG ETF Chart & Stats

Day’s Range― - ―
52-Week Range$24.70 - $38.97
Previous Close$25.75
VolumeN/A
Average Volume (3M)1.45M
AUM1.57B
NAV25.76
Expense Ratio0.75%
Holdings Count41
Beta1.73
Inception DateOct 31, 2014
Dividend YieldN/A
Shares Outstanding65,109,058
Standard Deviation0.12
10 Day Avg. Volume1,757,031
30 Day Avg. Volume1,452,248
Alpha-0.00696

ARKG ETF FAQ

What was ARKG’s price range in the past 12 months?
ARKG lowest ETF price was $24.70 and its highest was $38.97 in the past 12 months.
    What is the AUM of ARKG?
    As of Oct 17, 2023 The AUM of ARKG is 1.57B.
      Is ARKG overvalued?
      According to Wall Street analysts ARKG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does ARKG pay dividends?
        ARKG pays a Annually dividend of $0.38 which represents an annual dividend yield of N/A. See more information on ARKG dividends here
          How many shares outstanding does ARKG have?
          ARKG has 65,109,058 shares outstanding.
            Which hedge fund is a major shareholder of ARKG?
            Among the largest hedge funds holding ARKG’s share is ARK Investment Management LLC. It holds ARKG’s shares valued at 109K.

              ARKG ETF Smart Score

              For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

              Top 10 Holdings

              Name
              Weight %
              Exact Sciences Corp
              10.43%
              Ionis Pharmaceuticals Inc.
              7.09%
              Pacific Biosciences
              5.90%
              Ginkgo Bioworks Holdings, Inc.
              5.50%
              Teladoc Inc.
              4.65%
              Crispr Therapeutics
              4.40%
              Schrodinger, Inc.
              4.17%
              Intellia Therapeutics Inc
              3.98%
              Uipath Inc
              3.51%
              Beam Therapeutics, Inc.
              3.19%
              Total52.82%

              ETF Description

              ARK Genomic Revolution ETF

              ARKG is an actively managed fund that targets companies involved in the genomics industry.
              Sector
              Sector
              Asset Class
              Equity
              Region
              Global
              Issuer
              ARK
              Index Tracked
              No Underlying Index
              Ticker Symbol
              ARKG

              Popular ETFs

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis